Singapore Nuclear Medicine Market Size & Outlook
Singapore nuclear medicine market, 2018-2030 (US$M)
Related Markets
Singapore nuclear medicine market highlights
- The Singapore nuclear medicine market generated a revenue of USD 68.3 million in 2023 and is expected to reach USD 187.5 million by 2030.
- The Singapore market is expected to grow at a CAGR of 15.5% from 2024 to 2030.
- In terms of segment, diagnostics was the largest revenue generating product in 2023.
- Therapeutics is the most lucrative product segment registering the fastest growth during the forecast period.
Nuclear medicine market data book summary
| Market revenue in 2023 | USD 68.3 million |
| Market revenue in 2030 | USD 187.5 million |
| Growth rate | 15.5% (CAGR from 2023 to 2030) |
| Largest segment | Diagnostics |
| Fastest growing segment | Therapeutics |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Diagnostics, Therapeutics |
| Key market players worldwide | GE HealthCare Technologies Inc Common Stock, Jubilant Pharmova, Nordion, Bracco, Iren SpA, Abliva AB, Lantheus Holdings Inc, Eckert & Ziegler Bebig SA, Mallinckrodt PLC Ordinary Shares - New, Cardinal Health Inc |
Other key industry trends
- In terms of revenue, Singapore accounted for 0.7% of the global nuclear medicine market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan nuclear medicine market is projected to lead the regional market in terms of revenue in 2030.
- Singapore is the fastest growing regional market in Asia Pacific and is projected to reach USD 187.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Nuclear Medicine Market Scope
Nuclear Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Singapore nuclear medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear medicine market will help companies and investors design strategic landscapes.
Diagnostics was the largest segment with a revenue share of 70.86% in 2023. Horizon Databook has segmented the Singapore nuclear medicine market based on diagnostics, therapeutics covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing number of initiatives undertaken by key players is expected to propel market growth in Singapore. In June 2017, the Singapore Institute of Advanced Medical Holdings and Royal Philips collaborated with IBA Worldwide & Varian Medical Systems to build Advanced Medicine Oncology Centre, an international biomedical research hub, in Singapore.
The center would provide clinical informatics technologies, high-quality imaging, and treatment options to meet the needs of cancer patients in the country. In addition, growth in medical tourism and presence of organizations, such as Sing Health Group, that promote training and education in the field of nuclear medicines are expected to fuel market growth in the country.
Furthermore, local companies entering into partnerships with key players to boost manufacturing & supply of imaging agents is likely to fuel the market growth in Singapore. For instance, in September 2018, RADLINK’s radiopharmaceutical unit, Singapore Radiopharmaceuticals Pte Ltd became the exclusive manufacturer & supplier of GE Healthcare’s VIZAMYL in Singapore.
Reasons to subscribe to Singapore nuclear medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Singapore nuclear medicine market databook
-
Our clientele includes a mix of nuclear medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Singapore nuclear medicine market , including forecasts for subscribers. This country databook contains high-level insights into Singapore nuclear medicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Singapore nuclear medicine market size, by product, 2018-2030 (US$M)
Singapore Nuclear Medicine Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
